Quality assessment of labile blood products: An experience from a tertiary care hospital

##plugins.themes.academic_pro.article.main##

Najeh Sghair
Ikbel Ghachem
Kamel Boukef
Sonia Mahjoub

Abstract

Introduction-Aim : Quality control of blood products (BP) is a fundamental element in guaranteeing transfusion efficacy. The aim of our study was to evaluate the quality of red blood cell concentrates (RBCs) and fresh plasma (FP) produced at the Zaghouan blood bank, with reference to the requirements of the guide to good transfusion practices and international standards.


Methods : This is a cross-sectional study carried out at the Zaghouan blood bank. The first six bags of whole blood collected were selected. The volume of RBCs and FP were measured with an electronic balance and the hematocrit rate and hemoglobin content of RBCs were determined using a Mindray BC-5800 automated system.


Results : According to Tunisian standards, RBC volume, haemoglobin content, and haematocrit were compliant in 94.25%, 60.75%, and 95.5% of cases, respectively. These parameters met the European standards in 91.5%, 60.75%, and 44% of cases, respectively. The volume of 300 FPs complied with 93.6% and 100% of the European and Tunisian standards, respectively. Among 400 RBC units, 60.75% and 41.25% were compliant with Tunisian and international standards, respectively.


Conclusions : Quality control enabled us to identify non-conformities in the RBCs produced. We therefore recommend adjusting the volume of plasma extracted after whole blood centrifugation, including pre-donation haemoglobin levels in donor eligibility criteria, and extending the interval between two successive donations.

Keywords:

Quality control, concentrated red cells,, fresh plasma, blood bank

##plugins.themes.academic_pro.article.details##

References

  1. Organisation mondiale de la santé. Sécurité transfusionnelle et approvisionnement en sang. 2 juin 2023. Disponible sur : https://www.who.int/fr/news-room/fact-sheets/detail/blood-safety-and-availability
  2. (2)Franchini M, Capuzzo E, Turdo R, Glingani C. Quality of transfusion products in blood banking. Semin Thromb Hemost 2014;40:227–31. doi: 10.1055/s-0034-1365840.
  3. (3)Société africaine de transfusion sanguine : Référentiel programme d’accréditation par étape, préparation des produits sanguins, procédures pour la séparation, 2013, 27 P.
  4. (4) Hmida S, Boukef K. Transfusion safety in the Maghreb region. Transfus Clin Biol 2021;28:137–42. doi:10.1016/j.tracli.2021.01.014.
  5. (5)Haddad A, Elgemmezi T, Chaїb M, Bou Assi T, Abu Helu R, Hmida S et al. Quality and safety measures in transfusion practice: The experience of eight (6)southern/eastern Mediterranean countries. Vox Sang. 2020 Jul;115(5):405-423. doi: 10.1111/vox.12903 Ministère de la santé publique. Circulaire 04/2023 du 18 Janvier 2023 relative à la sécurité du transport du sang. Tunis: Ministère de la santé;2023.
  6. (7)Hassine M, Gargiuri J, Hmida S, Hafsia R, Maamar M, Sdiri M. Manuel des procédures de gestion du sang et de ses dérivés. Tunis: Ministère de la Santé Publique; 2010
  7. (8)Bouslama M, Abdelkefi S, Houissa B, Zaier M, Hmida H, Ghachem L, et al. Quality control of platelet concentrates: experience of Sousse (Tunisia) blood centre. Ann Biol Clin.2004;62:115–9.
  8. (9)Joudi K,Kalai S,Ben Hamed L, Briki S, Aloui D, Jerbi I et al. Production et contrôle de qualité des unités de plaquettes standards au Centre national de transfusion sanguine de Tunis. Transfus Clin Biol. 2017.24(3).336. Doi : 10.1016/j.tracli.2017.06.171
  9. (10)Direction européenne de la qualité du médicament & soins de santé - EDQM. Transfusion sanguine. Disponible sur : https://www.edqm.eu/en/blood
  10. (11)Conseil de l'Europe. Guide pour la préparation l’utilisation et l’assurance de la qualité des composants sanguins (Recommandation N° R (95) 15). 19ème éd. Strasbourg : Edition du conseil de l’Europe, 2017.
  11. (12)Mbanya D, Nouthe B, Tayou Tagny C, Moudourou S, Ngogang J. Concentrated red blood cells transfusion in Yaoundé, Cameroon: what quality?. Transfus Clin Biol.2007;14:453–6. doi:10.1016/j.tracli.2007.12.002.
  12. (13)Traore MB. Contrôle de qualité des concentrés de globules rouges au CNTS de Bamako [thèse]. Bamako: Université des Sciences, des Techniques et des Technologies; 2020
  13. Fétéké L, Mawussi K, Lakté P, kuéviakoé IM, Haudrechy D, Ségbéna AY. Contrôle interne de qualité des produits sanguins préparés au Centre National de Transfusion Sanguine, Lomé : La Tunisie médicale, 2008;Vol.86(7).698-703
  14. Magnang H, Padaro E, Mawussi K, Ouenangou T, Layibo Y, Kuéviakoé MDI, et al. Evaluation de la qualité des concentrés de globules rouges produits au Centre National de Transfusion Sanguine de Lomé. Pan Afr Med J. 2019;32:171. doi: 10.11604/pamj.2019.32.171.17680.
  15. Swiech A, Ausset S. Les produits sanguins labiles en 2016. Médecine Intensive Réanimation 2016;25:475–83. Doi :10.1007/s13546-016-1201-8.
  16. Yao KD, Kabore S, Siransy-Bogui L, Dembele B, Kouakou KD, Abisse S, et al. Contrôle qualité des produits sanguins labiles (PSL): expérience du Centre National de Transfusion Sanguine de Côte d'Ivoire de 2010 à 2013. Transfus Clin Biol. 2014;21:246. doi: 10.1016/j.tracli.2014.08.124.
  17. Upadhyay S, Pangtey T. Quality analysis of blood component (PRBC and platelet
  18. concentrates): a study from a tertiary care teaching hospital of Kumaon region of
  19. Uttarakhand. J Evol Med Dent Sci 2016;5:1210–3.
  20. Das SS, Biswas RN, Sardar TP, Safi M. An insight into the internal quality control of blood components separated using the latest whole blood collection and processing systems: Experience from a tertiary care hospital blood transfusion service in Eastern India. Asian J Transfus Sci. 2022;16:194–200. doi: 10.4103/ajts.ajts_52_21.
  21. Haddad A, Bou Assi T, Garraud O. How can Eastern/Southern Mediterranean countries resolve quality and safety issues in transfusion medicine? Front Med. 2018;5:45. doi: 10.3389/fmed.2018.00045.